Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

e0043 Effects of simvastatin on angiogenesis and the expression of Ang1 after myocardial infarction in rats

View through CrossRef
Objective To investigate the effects of simvastatin on myocardial angiogenesis and the expression of angiopoietin-1 after experimental myocardial infarction (MI) in rats. Methods 60 healthy adult SD rats were randomly divided into the sham operated group, the control group, low dose of simvastatin (1 mg·kg−1·d−1) group, medium dose of simvastatin (10 mg·kg−1·d−1) group, high dose of simvastatin (40 mg·kg−1·d−1) group. Left anterior descending coronary underwent permanent occlusion to establish the MI model. Rats were administered simvastatin respectively via oral gavage for four consecutive weeks starting at the next day. Density of new microvessels in the ischaemic area, LVMI, protein and mRNA expression of Ang-1 were detected 4 weeks after operation. Results (1) Compared with the control group, the Density of new microvessels in low and medium dose of simvastatin group increased significantly (p<0.05); and those did not changed significantly in high dose of simvastatin group (p>0.05) (2) LVMI in low and medium dose of simvastatin group decreased significantly compared with that in control group (p<0.05), and further decreased in high dose of simvastatin group. (3) The protein and mRNA expression of Ang-1 in all simvastatin group increased significantly compared with that in control group (p<0.05). Conclusion (1) Low and medium dose of simvastatin can stimulate myocardial angiogenesis after MI, wherase high dose of simvastatin have no pro-angiogenic effect. (2) the pro-angiogenic effect of simvastatin may be associated with upregulated expression of Ang-1.
Title: e0043 Effects of simvastatin on angiogenesis and the expression of Ang1 after myocardial infarction in rats
Description:
Objective To investigate the effects of simvastatin on myocardial angiogenesis and the expression of angiopoietin-1 after experimental myocardial infarction (MI) in rats.
Methods 60 healthy adult SD rats were randomly divided into the sham operated group, the control group, low dose of simvastatin (1 mg·kg−1·d−1) group, medium dose of simvastatin (10 mg·kg−1·d−1) group, high dose of simvastatin (40 mg·kg−1·d−1) group.
Left anterior descending coronary underwent permanent occlusion to establish the MI model.
Rats were administered simvastatin respectively via oral gavage for four consecutive weeks starting at the next day.
Density of new microvessels in the ischaemic area, LVMI, protein and mRNA expression of Ang-1 were detected 4 weeks after operation.
Results (1) Compared with the control group, the Density of new microvessels in low and medium dose of simvastatin group increased significantly (p<0.
05); and those did not changed significantly in high dose of simvastatin group (p>0.
05) (2) LVMI in low and medium dose of simvastatin group decreased significantly compared with that in control group (p<0.
05), and further decreased in high dose of simvastatin group.
(3) The protein and mRNA expression of Ang-1 in all simvastatin group increased significantly compared with that in control group (p<0.
05).
Conclusion (1) Low and medium dose of simvastatin can stimulate myocardial angiogenesis after MI, wherase high dose of simvastatin have no pro-angiogenic effect.
(2) the pro-angiogenic effect of simvastatin may be associated with upregulated expression of Ang-1.

Related Results

e0044 The role of Ang1 and eNOS in the proangiogenic effect of simvastatin after myocardial infarction in rats
e0044 The role of Ang1 and eNOS in the proangiogenic effect of simvastatin after myocardial infarction in rats
Objective To investigate the roles of angiopoietin-1 (Ang-1) and endothelial nitric oxide synthase (eNOS) in pro-angiogenic effect of simvastatin after experiment...
Efficacy and Pharmacokinetics of Simvastatin in Heart Transplant Recipients
Efficacy and Pharmacokinetics of Simvastatin in Heart Transplant Recipients
Objective: To evaluate the efficacy and safety of simvastatin administered to a group of heart transplant patients receiving triple-drug immunosuppressive thera...
GW24-e3967 Effects of simvastatin on vascular endothelial function in patients with coronary heart diseases
GW24-e3967 Effects of simvastatin on vascular endothelial function in patients with coronary heart diseases
Objectives To investigate the effects of simvastatin therapy on vascular endothelial function in patients with coronary heart diseases (CAD). ...
GW24-e3624 Myocardial regeneration in acute myocardial infarction rat model
GW24-e3624 Myocardial regeneration in acute myocardial infarction rat model
Objectives To investigate the myocardial proliferation/regeneration and myocardial cell apoptosis during different time points and in different parts of the heart...
Simvastatin Impairs Glucose Homeostasis in Mice Depending on PGC-1α Skeletal Muscle Expression
Simvastatin Impairs Glucose Homeostasis in Mice Depending on PGC-1α Skeletal Muscle Expression
Several studies showed an increased risk for diabetes with statin treatment. PGC-1α is an important regulator of muscle energy metabolism and mitochondrial biogenesis. Since statin...
Simvastatin dengan Senyawa Turunan Β-Siklodextrin
Simvastatin dengan Senyawa Turunan Β-Siklodextrin
This study aims to determine the profile of the inclusion complex formed between simvastatin and β-cyclodextrin and its derivatives. To determine the level of stability and determi...

Back to Top